AstraZeneca, an SAP customer for 20 years, is moving all of its ECC to the cloud

One of the largest SAP landscapes in the pharmaceutical industry is about to change homes. SAP announced on November 10 that AstraZeneca will migrate its entire environment to SAP Cloud ERP Private, through the RISE with SAP path.

This is not a partial move. The announcement calls it a full-estate migration. The company is leaving SAP ECC, the system that has run the operations of many large companies for decades, and going to SAP’s private cloud. Inside the drugmaker, the project has a name: the Axial program.

The two companies have worked together for 20 years. “This next chapter of our partnership is about much more than modernizing technology,” said Chris Taylor, Chief Information Officer at AstraZeneca. According to him, the idea is to simplify how the company operates and build the foundation to get more value from artificial intelligence.

That is where the second part of the announcement comes in. AstraZeneca is exploring SAP’s AI capabilities, including Joule, SAP’s assistant, and agents for finance, supply chain and manufacturing. That is the word used in the announcement: exploring. It does not say any of it is already in use.

The announcement also mentions SAP Business Data Cloud, to bring scattered data into a single foundation, and SAP Green Ledger, which connects sustainability data to business numbers.

What the announcement leaves out: timeline, contract value and how many systems will be migrated.

What changes for those running SAP in Brazil

Right away, nothing. But the calendar deserves a look. Mainstream maintenance for SAP ECC ends at the end of 2027, with an optional extension through 2030. For companies still on ECC in Brazil, two deadlines are running side by side: support, and the tax reform, which starts being charged in January 2027.

Sources

• Migration announcement: SAP News Center, Nov 10, 2026
• ECC maintenance timeline: SAP News Center, Feb 4, 2020

Official source: SAP News Center